SGLT2 inhibitors are a new family of agents, which occlude the path of SGLT2 glucose reabsorption and cause glucosuria. Efficacy of SGLT2 inhibitors includes reduction of HbA1c, fasting and ...

SGLT2 inhibitors for type 2 diabetes work by eliminating excess glucose in the urine. It not only brings the blood sugar down but also aids with weight reduction.

“Our data suggest SGLT2 inhibition as a safe strategy to prevent kidney stone recurrence in patients with kidney stones ,” Dr Fuster’s team concluded. Other study findings indicate the empagliflozin ...

Use of SGLT2 inhibitors was associated with a lower risk for rhabdomyolysis than DPP-4 inhibitors among statin users. Sodium-glucose cotransporter-2 (SGLT2) inhibitor use is associated with a ...

GLP-1 receptor agonists were more cardioprotective in younger people, but reduced HbA1c more with age. The age of type 2 ...

Diabetes statistics include: CKD statistics include: SGLT2 inhibitors work by blocking the kidneys from absorbing glucose (sugar). They help the kidneys eliminate excess sugar in the urine.

BOSTON -- Sodium-glucose cotransporter-2 (SGLT2) inhibitors were linked to long ... "I think we cannot make any major ...

The researchers found that both SGLT2 inhibitors and GLP-1 agonists were associated with a lower risk of major cardiovascular events, but the drug effects varied with the patients’ age.

SGLT-2 inhibitors, compared with DPP-4 inhibitors, were associated with a lower risk for liver cirrhosis among patients with type 2 diabetes. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors ...

SGLT2 inhibitors also lowered AKI risk, but “more work needs to be done to optimize their utilization, especially in high-risk populations in Asia and beyond.” ...

However, GLP-1 agonists had more effect in younger, female participants. Which diabetes treatment works best for who? “Both SGLT2 inhibitors and GLP-1 agonists are excellent drug categories that have ...